Cg Oncology Inc (NASDAQ:CGON) price on Wednesday, April 30, remained unchanged to $26.94.
A look at the stock’s price movement, the close in the last trading session was $26.94, moving within a range at $26.0 and $27.95. Turning to its 52-week performance, $46.99 and $14.80 were the 52-week high and 52-week low respectively. Overall, CGON moved 10.00% over the past month.
Cg Oncology Inc’s market cap currently stands at around $2.05 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-27.
The average forecast suggests down to a -72.66% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.16M, representing a 177.87% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CGON is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend CGON as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CGON’s current price about 30.22% and 11.46% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.05, while 7-day volatility ratio is 8.81% and 10.30% in the 30-day chart. Further, Cg Oncology Inc (CGON) has a beta value of 1.08, and an average true range (ATR) of 2.21. Analysts have given the company’s stock an average 52-week price target of $55, forecast between a low of $55 and high of $55. Looking at the price targets, the low is -104.16% off current price level while to achieve the yearly target high, price needs to move -104.16%. Nonetheless, investors will most likely welcome a -104.16% jump to $55 which is the analysts’ median price.
If we refocus on Cg Oncology Inc (NASDAQ:CGON), historical trading data shows that trading volumes averaged 2.2 over the past 10 days and 1.05 million over the past 3 months. The company’s latest data on shares outstanding shows there are 76.15 million shares.
The 39.60% of Cg Oncology Inc’s shares are in the hands of company insiders while institutional holders own 67.17% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.09 million on 2025-04-15, giving us a short ratio of 7.2. The data shows that as of 2025-04-15 short interest in Cg Oncology Inc (CGON) stood at 1202.0001 of shares outstanding, with shares short rising to 7.23 million registered in 2025-03-14. Current price change has pushed the stock -6.07% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CGON stock continues to rise going into the next quarter.
